Close
  Indian J Med Microbiol
 

Figure 3: Patients with no lesions, mild (<10 lesions), moderate (11–49 lesions), and severe scabies (>50 lesions) at baseline and follow-up in the Group B, oral ivermectin group (n = 50). P < 0.001 at 1st and 2nd weeks

Figure 3: Patients with no lesions, mild (<10 lesions), moderate (11–49 lesions), and severe scabies (>50 lesions) at baseline and follow-up in the Group B, oral ivermectin group (<i>n</i> = 50). <i>P</i> < 0.001 at 1<sup>st</sup> and 2<sup>nd</sup> weeks